Campbell's Slashes Dividend 36% Amid Q4 Loss, $117M Impairment, and Weak FY27 Outlook
CPB is trading near its 52-week low of $19.555 (8.5% above the low).
Summary
Campbell's posted a Q4 loss, took a $117M impairment on snack brands, cut its dividend 36%, and guided FY2027 adjusted EPS down 24-17%.
Key Events · Earnings and Guidance · CPB
-
Q4 Loss and Full-Year Decline
Q4 net sales fell 8% to $2.1B with a GAAP EPS loss of $(0.23); full-year adjusted EPS dropped 27% to $2.17.
-
Dividend Cut 36%
Quarterly dividend reduced from $0.39 to $0.25 per share ($1.00 annualized) to accelerate debt reduction; payable November 2, 2026.
-
$117M Trademark Impairment
Combined impairment on Cape Cod and Kettle Brand trademarks within the Snacks segment drove Q4 other expenses to $147M.
-
FY2027 Guidance Well Below Expectations
Adjusted EPS guided to $1.65-$1.80, a 24-17% decline; net sales expected to fall 4-2%.
Analysis · CPB · Manufacturing
A $117 million impairment on the Cape Cod and Kettle Brand trademarks pushed Campbell's to a GAAP loss of $0.23 per share in Q4, and the company cut its quarterly dividend 36% to $0.25 per share to accelerate debt reduction. Full-year adjusted EPS fell 27% to $2.17, while fiscal 2027 guidance of $1.65 to $1.80 per share implies another 24% to 17% decline. The dividend reset is the most consequential action — it signals management is prioritizing balance sheet repair over shareholder returns, a major shift for a company long viewed as a dividend stalwart.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CPB was trading at $21.22 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $19.56 to $34.18. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.